| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/02/2005 | US20050118590 Novel gene cluster of pederin biosynthesis genes |
| 06/02/2005 | US20050118587 Method and kit for detection of novel pathogen inhibitors |
| 06/02/2005 | US20050118586 Expression vector comprising nucleotide sequences coding heterologous polypeptide for use in forensic analysis as chromosome, tissue, cell and organelle specific markers |
| 06/02/2005 | US20050118585 Using allelic variation in bone morphogenic signaling family proteins as diagnostic tool in detection of vision defcets |
| 06/02/2005 | US20050118583 Novel genetic products of ashbya gossypii, associated with the mechanisms of signal transduction and especially with the improvement of vitamin b2 production |
| 06/02/2005 | US20050118582 Nucleoprotein for use as tool in treatment, diagnosis and prevention of infection, cell proliferative, neurological, developmental, autoimmune and inflammatory disorders |
| 06/02/2005 | US20050118581 Novel brain expressed gene and protein associated with bipolar disorder |
| 06/02/2005 | US20050118580 Nucleic acid which is stabilized against decomposition |
| 06/02/2005 | US20050118579 Using allelic variation in canalicular multispecific organic anion transporter (cMOAT) gene as diagnostic tool in detection of liver and bile duct disorders |
| 06/02/2005 | US20050118575 Immune cell polypeptide for use in diagnosis and treatment of cell proliferative disorders |
| 06/02/2005 | US20050118573 Nucleic sequence and deduced protein sequence family with human endogenous retroviral motifs, and their uses |
| 06/02/2005 | US20050118571 Nucleic acids comprising viral genome and ribozyme sequences for use in animal models system for designing treatments for prevention of hepatitis viral infection |
| 06/02/2005 | US20050118569 Genetic engineering of streptavidin-binding peptide tagged single-chain variable fragment antibody to venezuelan equine encephalitis virus |
| 06/02/2005 | US20050118568 Method for detecting human papillomavirus mrna |
| 06/02/2005 | US20050118566 Replicons derived from positive strand rna virus genomes useful for the production of heterologous proteins |
| 06/02/2005 | US20050118300 Soybean raffinose synthase and a method for producing raffinose |
| 06/02/2005 | US20050118253 comprising a nucleic acid that is fully encapsulated within a lipid; for treating a neoplasia in a mammal |
| 06/02/2005 | US20050118195 Virus causing respiratory tract illness in susceptible mammals |
| 06/02/2005 | US20050118192 Viral preparations, vectors, immunogens, and vaccines |
| 06/02/2005 | US20050118191 Optimization of gene sequences of chimeric virus-like particles for expression in insect cells |
| 06/02/2005 | US20050118189 Mutant Hin47 protein with decreased protease activity, and a high molecular weight protein of a strain of non-typeable Haemophilus influenzae; may be combined with diphtheria or tetanus toxoids, pertussis antigens or non-virulent poliovirus; immunization; otitis media |
| 06/02/2005 | US20050118184 Compositions and methods for enhancing the immunogenicity of antigens |
| 06/02/2005 | US20050118183 Anti-CD33 antibodies and method for treatment of acute myeloid leukemia using the same |
| 06/02/2005 | US20050118176 Inhibiting binding of interleukin-4 (IL-4) to an IL-4 Receptor; suppressing an IL-4-dependent immune or inflammatory response in a mammal |
| 06/02/2005 | US20050118162 Treatment of micro-organism infection |
| 06/02/2005 | US20050118161 Hevein-binding monoclonal antibodies |
| 06/02/2005 | US20050118160 Inhibits delayed vascular rejection; makes organs less vulnerable to rejection after transplantation |
| 06/02/2005 | US20050118159 recombinant DNA molecules that express homogenous lysostaphin and host cells transformed with these DNA molecules |
| 06/02/2005 | US20050118150 Population of hematopoietic cells, made to exhibit a greater clonogenic potential, engraftment potential, immune system reconstitution potential and/or proportion of CD34+ positive cells by culturing with a transition metal compound that chelates copper such as tetraethylenepentamine |
| 06/02/2005 | US20050118148 Compositions and methods related to mammalian Maf-A |
| 06/02/2005 | US20050118140 Madin Darby Canine Kidney cells are virally infected and cultured in suspension on an industrial scale to produce the active ingredient, and then mixed with a carrier or dilluent |
| 06/02/2005 | US20050118139 Canine papillomavirus E genes are codon-optimized to enhance expression in host cells; the vector is an adenovirus vector or a plasmid vector, and the genes are from a human papillomavirus serotype; prevention and prophylaxis |
| 06/02/2005 | US20050118117 Methods for identifying risk of melanoma and treatments thereof |
| 06/02/2005 | US20050115897 Extraction and winterization of lipids from oilseed and microbial sources |
| 06/02/2005 | DE10349441A1 Selecting nucleic acid that binds target molecules, useful potentially as therapeutic agents, by screening short sequences with two fixed regions flanking a random region |
| 06/02/2005 | DE10163098B4 Verfahren zur Hemmung der Replikation von Viren A method of inhibiting the replication of viruses |
| 06/02/2005 | DE10057841B4 Verfahren zum Nachweis von Protozoen der Gattung Naegleria A method for the detection of protozoa of the genus Naegleria |
| 06/02/2005 | DE10049267B4 Verfahren zur Erzeugung oder Erhöhung einer Resistenz in Organismen gegenüber biotischen Streßfaktoren A method for generating or increasing a resistance in organisms to biotic stress factors |
| 06/02/2005 | CA2844236A1 Improved targeted dna insertion in plants |
| 06/02/2005 | CA2547087A1 Ice recrystallisation inhibition protein or antifreeze proteins from deschampsia, lolium and festuca species of grass |
| 06/02/2005 | CA2547079A1 Dna vaccines encoding hsp60 peptide fragments for treating autoimmune diseases |
| 06/02/2005 | CA2546873A1 Surface-located campylobacter jejuni polypeptides |
| 06/02/2005 | CA2546860A1 Ocular tissue modification |
| 06/02/2005 | CA2546840A1 Immunization against chlamydia infection |
| 06/02/2005 | CA2546836A1 Immunization against chlamydia infection |
| 06/02/2005 | CA2546698A1 Method |
| 06/02/2005 | CA2546678A1 Method for producing l-amino acid by fermentation |
| 06/02/2005 | CA2546674A1 Plants having modified growth characteristics and a method for making the same |
| 06/02/2005 | CA2546566A1 Chimeric anti cd44 antibodies and their use for treating acute myeloid leukemia |
| 06/02/2005 | CA2546355A1 Novel atypical pneumonia-causing virus |
| 06/02/2005 | CA2546074A1 Syk-targeted nucleic acid interference |
| 06/02/2005 | CA2546067A1 Fcyriia-specific nucleic acid interference |
| 06/02/2005 | CA2545697A1 Self-cleaving ribozymes and uses thereof |
| 06/02/2005 | CA2545693A1 Modification of protein glycosylation in methylotrophic yeast |
| 06/02/2005 | CA2545564A1 Improved targeted dna insertion in plants |
| 06/02/2005 | CA2545049A1 Method for proliferating cardiomyocytes |
| 06/02/2005 | CA2544805A1 Nucleic acids specifically binding bioactive ghrelin |
| 06/02/2005 | CA2543897A1 Compositions and methods for screening pro-apoptotic compounds |
| 06/02/2005 | CA2541294A1 Rna virus-derived plant expression system |
| 06/02/2005 | CA2527680A1 Markers for responsiveness to an erbb receptor tyrosine kinase inhibitor |
| 06/02/2005 | CA2526860A1 Synthetic mammalian retrotransposon gene |
| 06/02/2005 | CA2515890A1 Novel insertion sites in pox vectors |
| 06/01/2005 | EP1536234A2 Soluble CTLA4 mutant molecules and uses thereof |
| 06/01/2005 | EP1536019A1 Using a polymerase with 3' to 5' exonuclease activity to perform gene sequence analysis |
| 06/01/2005 | EP1536015A1 Promoters for expression in modified vaccinia virus ankara |
| 06/01/2005 | EP1536014A1 Process for producing glucose dehydrogenases |
| 06/01/2005 | EP1536013A1 Dna sequence useful in diagnosing hepatitis and polypeptide encoded thereby |
| 06/01/2005 | EP1536012A1 Human antihuman interleukin-6 antibody and fragment of the antibody |
| 06/01/2005 | EP1536011A1 Preventives/remedies for neurodegenerative diseases |
| 06/01/2005 | EP1536010A1 Preventives/remedies for cancer |
| 06/01/2005 | EP1536009A1 Hla-a24-restricted cancer antigen peptide |
| 06/01/2005 | EP1536007A1 Artificial mammalian chromosome |
| 06/01/2005 | EP1536006A1 Cancer antigens and utilization thereof |
| 06/01/2005 | EP1536005A1 Method of assaying interaction between proteins |
| 06/01/2005 | EP1536004A1 Method of promoting homologous recombination of somatic cells and method of constructing specific antibody |
| 06/01/2005 | EP1536003A1 Method of detecting gene polymorphism |
| 06/01/2005 | EP1536002A1 Yeast-origin promoter and vector and expression system using the same |
| 06/01/2005 | EP1536001A1 Method of diagnosing risk of restenosis after coronary angioplasty |
| 06/01/2005 | EP1536000A1 Method of judging inflammatory disease |
| 06/01/2005 | EP1535998A1 Plant nucleotide-sugar pyrophosphatase/phosphodiesterase (nppase), method of obtaining same and use of same in the production of assay devices and in the production of transgenic plants |
| 06/01/2005 | EP1535996A1 Glucose dehydrogenase |
| 06/01/2005 | EP1535995A1 Polynucleotides encoding the antigenic HIV type C env polypeptide and uses thereof |
| 06/01/2005 | EP1535993A1 Biomolecule transfer method using virus envelope and composition and system therefor |
| 06/01/2005 | EP1535992A1 Maize nucleotide sequence coding for a protein with transglutaminase activity and use thereof |
| 06/01/2005 | EP1535991A2 Method and device for targeted delivery of materials to selected single cells |
| 06/01/2005 | EP1535929A2 Megakaryocyte stimulating factors |
| 06/01/2005 | EP1535928A2 Omp85 proteins of Neisseria gonorrhoeae and Neisseria meningitidis, compositions containing same and methods of use thereof |
| 06/01/2005 | EP1535666A1 Microchannel array component, microchannel array for recovering biomolecules, and method for recovering biomolecules |
| 06/01/2005 | EP1535628A2 HBV/HCV virus-like particle |
| 06/01/2005 | EP1535627A1 Recombinant bcg vaccine |
| 06/01/2005 | EP1535614A2 Materials and methods for detection and treatment of immune system dysfunctions |
| 06/01/2005 | EP1535512A1 DISEASE MODEL ANIMAL CARRYING FOREIGN PPARa GENE TRANSFERRED THEREINTO AND USE THEREOF |
| 06/01/2005 | EP1535232A2 A system and method for snp genotype clustering |
| 06/01/2005 | EP1535072A1 Probe carrier and method of producing same |
| 06/01/2005 | EP1535070A1 Nano-sized optical fluorescence labels and uses thereof |
| 06/01/2005 | EP1535067A2 PAPSSs AS MODIFIERS OF THE AXIN PATHWAY AND METHODS OF USE |
| 06/01/2005 | EP1535065A2 Neuroprotective synergy of erythropoietin and insulin-like growth factor |
| 06/01/2005 | EP1535063A2 Method for analyzing readings of nucleic acid assays |
| 06/01/2005 | EP1534865A2 Methods and compositions for determining methylation profiles |
| 06/01/2005 | EP1534862A2 Modulators of rabggt and methods of use thereof |